FDA Inspection 1257601 — Nicola A. Bridges, MD
The FDA completed an inspection of Nicola A. Bridges, MD on Oct 24, 2024 in London. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 24, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- London (United Kingdom)
Additional details
Clinical Investigator (CI)